118 related articles for article (PubMed ID: 29324755)
21. Liver fibrosis after antiretroviral therapy in a longitudinal cohort of sexually infected HIV patients in eastern China.
Wei Q; Lin H; Ding Y; Liu X; Wu Q; Shen W; Gao M; He N
Biosci Trends; 2017 Jul; 11(3):274-281. PubMed ID: 28484111
[TBL] [Abstract][Full Text] [Related]
22. Pitfalls of HIV genotypic tropism testing after treatment interruption.
Wirden M; Soulié C; Fourati S; Valantin MA; Simon A; Ktorza N; Tubiana R; Bonmarchand M; Schneider L; Calvez V; Katlama C; Marcelin AG
J Antimicrob Chemother; 2013 Jan; 68(1):188-9. PubMed ID: 22954492
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection.
Bon I; Clò A; Borderi M; Colangeli V; Calza L; Morini S; Miserocchi A; Cricca M; Gibellini D; Re MC
Int J Infect Dis; 2013 Oct; 17(10):e875-82. PubMed ID: 23597487
[TBL] [Abstract][Full Text] [Related]
24. Impact of baseline HIV-1 tropism on viral response and CD4 cell count gains in HIV-infected patients receiving first-line antiretroviral therapy.
Seclén E; Soriano V; González MM; Martín-Carbonero L; Gellermann H; Distel M; Kadus W; Poveda E
J Infect Dis; 2011 Jul; 204(1):139-44. PubMed ID: 21628668
[TBL] [Abstract][Full Text] [Related]
25. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M
J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
[TBL] [Abstract][Full Text] [Related]
26. Genotypic tropism of antiretroviral-treated patients with drug resistant HIV-1.
Parczewski M; Leszczyszyn-Pynka M; Urbanska A; Bander D; Boron-Kaczmarska A
J Med Virol; 2011 Nov; 83(11):1869-75. PubMed ID: 21915859
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
Mussini C; Lorenzini P; Puoti M; Lichtner M; Lapadula G; Di Giambenedetto S; Antinori A; Madeddu G; Cozzi-Lepri A; d'Arminio Monforte A; De Luca A;
PLoS One; 2015; 10(12):e0140877. PubMed ID: 26640953
[TBL] [Abstract][Full Text] [Related]
28. Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia.
Seclén E; Del Mar González M; De Mendoza C; Soriano V; Poveda E
J Antimicrob Chemother; 2010 Jul; 65(7):1493-6. PubMed ID: 20488982
[TBL] [Abstract][Full Text] [Related]
29. The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients.
Santoro MM; Armenia D; Fabeni L; Santoro M; Gori C; Forbici F; Svicher V; Bertoli A; Dori L; Surdo M; Balestra E; Palamara G; Girardi E; Angarano G; Andreoni M; Narciso P; Antinori A; Ceccherini-Silberstein F; Perno CF
Clin Microbiol Infect; 2012 Aug; 18(8):E289-98. PubMed ID: 22681969
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance.
de Mendoza C; Rodriguez C; García F; Eiros JM; Ruíz L; Caballero E; Aguilera A; Leiva P; Colomina J; Gutierrez F; del Romero J; Aguero J; Soriano V;
J Antimicrob Chemother; 2007 Apr; 59(4):698-704. PubMed ID: 17327295
[TBL] [Abstract][Full Text] [Related]
31. Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.
Zhou S; Bednar MM; Sturdevant CB; Hauser BM; Swanstrom R
J Virol; 2016 Aug; 90(16):7142-58. PubMed ID: 27226378
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
Soulié C; Marcelin AG; Ghosn J; Amellal B; Assoumou L; Lambert S; Duvivier C; Costagliola D; Katlama C; Calvez V
AIDS; 2007 Oct; 21(16):2243-5. PubMed ID: 18090053
[TBL] [Abstract][Full Text] [Related]
33. Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies.
McGovern RA; Thielen A; Mo T; Dong W; Woods CK; Chapman D; Lewis M; James I; Heera J; Valdez H; Harrigan PR
AIDS; 2010 Oct; 24(16):2517-25. PubMed ID: 20736814
[TBL] [Abstract][Full Text] [Related]
34. Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial.
Charpentier C; Joly V; Larrouy L; Fagard C; Visseaux B; de Verdière NC; Raffi F; Yeni P; Descamps D;
J Antimicrob Chemother; 2013 Mar; 68(3):690-6. PubMed ID: 23152480
[TBL] [Abstract][Full Text] [Related]
35. Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine.
Kooij KW; Wit FW; van Zoest RA; Schouten J; Kootstra NA; van Vugt M; Prins M; Reiss P; van der Valk M;
AIDS; 2016 Jul; 30(11):1771-80. PubMed ID: 27088320
[TBL] [Abstract][Full Text] [Related]
36. Differences in coreceptor specificity contribute to alternative tropism of HIV-1 subtype C for CD4(+) T-cell subsets, including stem cell memory T-cells.
Cashin K; Paukovics G; Jakobsen MR; Østergaard L; Churchill MJ; Gorry PR; Flynn JK
Retrovirology; 2014 Nov; 11():97. PubMed ID: 25387392
[TBL] [Abstract][Full Text] [Related]
37. Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years.
Briz V; Poveda E; del Mar González M; Martín-Carbonero L; González-González R; Soriano V
J Antimicrob Chemother; 2008 Feb; 61(2):405-10. PubMed ID: 18063598
[TBL] [Abstract][Full Text] [Related]
38. Switch of predicted HIV-1 tropism in treated subjects and its association with disease progression.
Castagna A; Monno L; Carta S; Galli L; Carrara S; Fedele V; Punzi G; Fanti I; Caramello P; Lepri AC; De Luca A; Ceccherini-Silberstein F; Monforte AD;
Medicine (Baltimore); 2016 Nov; 95(44):e5222. PubMed ID: 27858869
[TBL] [Abstract][Full Text] [Related]
39. Partial HIV C2V3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among Kenyan patients on HAART.
Kitawi RC; Hunja CW; Aman R; Ogutu BR; Muigai AW; Kokwaro GO; Ochieng W
Virol J; 2017 Feb; 14(1):29. PubMed ID: 28196510
[TBL] [Abstract][Full Text] [Related]
40. Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan.
Chou CC; Tsai HC; Wu KS; Sy CL; Chen JK; Chen YS; Lee SS
J Microbiol Immunol Infect; 2016 Aug; 49(4):546-53. PubMed ID: 25440980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
